Skip to main content
. 2011 Mar 27;15(2):R102. doi: 10.1186/cc10117

Table 4.

Characteristics and outcomes of PMV patients eligible for four different models of weaning units

Unit A
(n = 101)
Unit B
(n = 113)
Unit C
(n = 110)
Unit D
(n = 117)




Weaning unit description No vasoactive treatment or RRT for 7 days No vasoactive treatment or RRT for 2 days No vasoactive treatment
for 7 days
No vasoactive treatment
for 2 days
Age (mean (SD)) 59 (15) 58 (16) 59 (16) 58 (16)
Sex n (%) female 45 (45) 48 (43) 48 (44) 50 (43)
Surgical status n (%)
 Elective 2 (2) 2 (2) 2 (2) 2 (2)
 Emergency 11 (11) 12 (11) 13 (12) 13 (11)
 Non-surgical 88 (87) 99 (88) 95 (86) 102 (87)
APACHE II score (mean (SD))a 20.7 (7.0) 20.7 (7.0) 21.0 (6.9) 20.9 (7.0)
Tracheostomy on reaching eligibility for unit; n (%) 94 (93) 102 (90) 102 (93) 106 (91)
Length of ICU stay after reaching eligibility (days)
 Mean (SD) 14.9 (13.4) 14.9 (13.9) 14.9 (13.5) 15.3 (14.0)
 Median (IQR) 11 (6 to 22) 11 (5 to 22) 11 (5 to 22) 11 (5 to 23)
Days ventilated after reaching eligibility
 Mean (SD) 11.3 (11.8) 11.6 (12.2) 11.5 (11.9) 12.0 (12.2)
 Median (IQR) 7 (3 to 17) 7 (3 to 17) 7 (3 to 17) 8 (4 to 17)
Proportion of funded ICU bed-days used by population after reaching eligibility 8.1% 9.1% 8.9% 9.7%
Possible readmissions to ICU per year n (%)b 15 (15) 21 (19) 17 (16) 21 (18)
Mortality at ICU discharge n (%) 14 (14) 19 (17) 19 (17) 22 (19)
Mortality at final hospital discharge n (%)c 29 (32) 35 (34) 34 (34) 38 (36)

a n for APACHE II score: n = 88, n = 97, n = 96, n = 101; b patients who would be transferred out of the weaning unit due to clinical instability, either requiring vasoactive therapy or RRT (units A and B) or vasoactive therapy alone (units C and D); c n for mortality at final hospital discharge: n = 91, n = 102, n = 99, n = 106 for units A to D, respectively.

APACHE, Acute Physiology and Chronic Health Evaluation; IQR, interquartile range; PMV, prolonged mechanical ventilation; RRT, renal replacement therapy; SD, standard deviation.